Clinical trial
High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda: a Feasibility Trial
NCT04088591 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda: a Feasibility Trial
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- October 31, 2022
- Completion date
- December 31, 2023
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.